Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan
· Delayed Price · Currency is TWD 32.50
+0.85 (2.69%)
Mar 10, 2026, 1:59 PM CST
Great Novel Therapeutics Biotech & Medicals Company Description
Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers.
The company develops drugs for cancer immunotherapy, including tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors.
The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei, Taiwan.
Great Novel Therapeutics Biotech & Medicals
| Country | Taiwan |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Chia-Nan Chen |
Contact Details
Address: No.508, Zhongxiao East Road Taipei, 115 Taiwan | |
| Phone | 886 2 2785 1399 |
| Website | gntbm.com.tw |
Stock Details
| Ticker Symbol | 7427 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0007427007 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Chia-Nan Chen | President and Chairman of the Board |
| Chen-Chia Tang | Financial and Accounting Manager |
| Yingzhang Huang | Accounting Supervisor |
| Pei-Ching Hsu | Director of Administration Department |